期刊
ANNUAL REVIEW OF MEDICINE, VOL 69
卷 69, 期 -, 页码 65-79出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev-med-041316-090654
关键词
diastolic heart failure; pulmonary hypertension; cardiomyopathy; hypertension
资金
- NHLBI NIH HHS [R01 HL105418, U10 HL110262] Funding Source: Medline
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110262] Funding Source: NIH RePORTER
Heart failure (HF) is a clinical syndrome of diverse etiologies and can be associated with preserved, reduced, or mid-range ejection fraction (EF). In the community, heart failure with preserved ejection fraction (HFpEF) is emerging as the most common form of HF. There remains considerable uncertainty regarding its pathogenesis, diagnosis, and optimal therapeutic approach. Hypotheses have been advanced to explain the underlying pathophysiology responsible for HFpEF, but to date, no specific therapy based on these hypotheses has been proven to improve outcomes in HFpEF. We provide a clinically focused review of the epidemiology, clinical presentation, diagnostic approach, pathophysiology, and treatment of HFpEF.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据